[1] World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021. https://www.who.int/publications/i/item/9789240037021.https://www.who.int/publications/i/item/9789240037021
[2] Li BY, Shi WP, Zhou CM, Zhao Q, Diwan VK, Zheng XB, et al. Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling. Infect Dis Poverty 2020;9(1):65. http://dx.doi.org/10.1186/s40249-020-00682-7CrossRef
[3] Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health 2017;17(1):221. http://dx.doi.org/10.1186/s12889-017-4089-yCrossRef
[4] Ruan YZ, Li L, Xu L, Zhao YL, Zhong L, Xu ZX, et al. Practical experiences of delivering multidrug-resistant tuberculosis comprehensive supportive care services in China. China CDC Wkly 2021;3(26):566 − 8. http://dx.doi.org/10.46234/ccdcw2021.146CrossRef
[5] Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, et al. A trial of a shorter regimen for rifampin-resistant tuberculosis. N Engl J Med 2019;380(13):1201 − 13. http://dx.doi.org/10.1056/NEJMoa1811867CrossRef
[6] Ngwatu BK, Nsengiyumva NP, Oxlade O, Mappin-Kasirer B, Nguyen NL, Jaramillo E, et al. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J 2018;51(1):1701596. http://dx.doi.org/10.1183/13993003.01596-2017CrossRef
[7] Subbaraman R, de Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE, et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob Health 2018;3(5):e001018. http://dx.doi.org/10.1136/bmjgh-2018-001018CrossRef
[8] Riquelme-Miralles D, Palazón-Bru A, Sepehri A, Gil-Guillén VF. A systematic review of non-pharmacological interventions to improve therapeutic adherence in tuberculosis. Heart Lung 2019;48(5):452 − 61. http://dx.doi.org/10.1016/j.hrtlng.2019.05.001CrossRef
[9] Wang N, Li T, Du X, Li Y, Sun MM, Huan ST, et al. Effectiveness of the integrated TB surveillance system — China, 2018-2019. China CDC Wkly 2020;2(12):190-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393169/.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393169/